Figure 3.
Letermovir efficacy in preventing csCMVi by week 14 according to subgroups in period 2 compared to period 1.

Letermovir efficacy in preventing csCMVi by week 14 according to subgroups in period 2 compared to period 1.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal